Case Report
Metastasis of Ewing Sarcoma to the Pancreas: Case Report and Literature Review
Table 2
Summary of markers in 39 ESFT cases with pancreatic involvement reported to date.
| Marker | Number of times reported positive |
| CD99 | 31 (78%) | Neuron specific enolase (NSE) | 16 (40%) | Vimentin | 12 (30%) | Synaptophysin | 9 (23%) | Cytokeratin AE1/AE3 | 7 (18%) | Chromagranin | 4 (10%) | S-100 | 4 (10%) | Epithelial membrane antigen | 4 (10%) | PAS | 3 (7.5%) | CD56 | 3 (7.5%) | Neural cell adhesion molecule | 1 (2.5%) | FLI-1 | 1 (2.5%) | Cytokeratin 8 | 1 (2.5%) | CD45 | 1 (2.5%) | Alpha 1 antichromotrypsin | 1 (2.5%) | CKM | 1 (2.5%) | Progesterone receptor | 1 (2.5%) | Estrogen receptor | 1 (2.5%) | Inhibin | 1 (2.5%) | Cyclin D | 1 (2.5%) | Leu 7 | 1 (2.5%) | BCL-2 | 1 (2.5%) | CK 19 | 1 (2.5%) | CAM 5.2 | 1 (2.5%) | β-Catenin | 1 (2.5%) | 12E7 | 1 (2.5%) |
|
|